Bukwang Pharmaceutical IND

부광약품 · 003000

Health Care Pharmaceuticals · KOSPI

Small-cap

Market cap US$328.5M (₩453.4B)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$145.4M

▲ +25.4% YoY

Operating profit · FY2025

US$10.3M

▲ +775.6% YoY

Net income · FY2025

US$9M

Turned profitable

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$91.3M(₩125.9B)	US$116M(₩160.1B)	US$145.4M(₩200.7B)
Operating profit	−US$27.2M(−₩37.5B)	US$1.2M(₩1.6B)	US$10.3M(₩14.2B)
Net income	−US$24.9M(−₩34.4B)	−US$2.5M(−₩3.5B)	US$9M(₩12.4B)

Revenue

Operating profit

Net income

ROE

3.6%

Debt/Eq

39.7%

Op. margin

7.1%

Net margin

6.2%

Rev. YoY

▲ +25.4%

Interactive price history isn't here yet. Would you use it?